Immunotherapy Bearish Overreaction Can Create Opportunity – Seeking Alpha
|
Immunotherapy Bearish Overreaction Can Create Opportunity
Seeking Alpha Cramer recognizes the immunotherapy sector is being hit across the board on any bad news about one. The technology has produced results for some companies which have resulted in FDA approval; is this a market overreaction? Technically this sector's … |
